Science Corp., a developer of brain-computer interfaces and other medical equipment, today announced that it has raised $230 million in funding. The capital came from a consortium that included ...
Implantable device research from the BrainGate clinical trial enables communication through rapid typing for a patient with ...
China’s medical regulator has granted a world-first commercial green light to a brain-computer interface, with a system ...
Brain-computer interface, an innovative technology frontier that establishes a direct link between the human brain and ...
As the tech industry shifts toward artificial intelligence agents and generative user interfaces, helping loved ones use ...
China's drug regulator has approved the world's first commercial brain-computer interface (BCI) system, designed to restore hand movement in quadriplegic patients.
In a pivotal trial of Science’s Prima BCI, 84% of patients impacted by dry AMD were able to read again once fitted with the technology.
A brain-computer interface allowed two people who had lost the ability to move their limbs to type at speeds of up to 22 words per minute ...
A source close to the company says the round assigns Science a post-money valuation of $1.25 billion.
Beijing elevated BCIs to a core future strategic industry in its new five-year plan released this week, placing it alongside sectors such as quantum, embodied AI, 6G and nuclear fusion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results